In all cases of stage I–III CRC, surveillance after surgery is routinely recommended with a combination of clinical, radiographic, endoscopic, and/or serologic (carcinoembryonic antigen or CEA) assessments over time to detect recurrences [2,4,9,13]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.